Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Novacyt (NYZ) Stock Price & Analysis

NYZ Stock Chart & Stats

€0.42-€0.02(-4.60%)
At close: 5:30 PM GMT+1
EUR 0.5EUR 1EUR 1.58 Sep3 Mar21 Dec11 Apr30 Aug19 Feb8 Oct6 Mar24 Sep
Day’s Range
EUR 0.42 - EUR 0.44
52-Week Range
EUR 0.29 - EUR 0.97
Previous Close
EUR 0.44
Volume
0
Average Volume (3M)
744
Market Cap
EUR 31.94M
Enterprise Value
EUR 29.84M
Total Cash (Recent Filing)
EUR 8.88M
Total Debt (Recent Filing)
EUR 10.19M
Price to Earnings (P/E)
―
Beta
0.12
Next Earnings
Apr 29, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Sustained Revenue Growth

Three consecutive half-years of growth, including 18% year-on-year expansion, indicate improving commercial traction rather than a single-period rebound. Continued growth across regions and business lines can broaden the revenue base and support operating leverage as Novacyt scales.

Product And Market Expansion

IVDR approval expands the addressable market for the DPYD assay and supports commercialization across Europe and other served geographies. A clinically targeted product addressing chemotherapy dosing can strengthen Novacyt’s portfolio and create recurring diagnostic demand.

Strategic Illumina Partnership

A five-year collaboration with Illumina provides a durable commercial and technical relationship with an established diagnostics platform. Successful delivery can deepen Novacyt’s industry credibility, support future projects, and improve the visibility of partnership-related activity.

Bears Say

Persistent Losses And Cash Burn

Deep losses and negative operating and free cash flow show that revenue growth has not yet translated into self-funding operations. Continued cash consumption can constrain investment, increase dependence on financing, and leave execution vulnerable until the cost base and margins improve.

Gross-margin Pressure

The margin decline shows that mix and acquisition effects can dilute the economics of growth, particularly as lower-margin distribution revenue expands. Recovering margins above 60% remains a stated ambition, but the current mix creates a lasting profitability challenge during integration.

Restructuring Remains Incomplete

The incomplete restructuring means the planned cost benefits are not yet fully secured, while additional exceptional charges may weigh on near-term results. Until implementation finishes, management must deliver savings while absorbing disruption and continuing to fund an EBITDA-loss-making business.

Novacyt News

NYZ FAQ

What was Novacyt’s price range in the past 12 months?
Novacyt lowest stock price was €0.29 and its highest was €0.97 in the past 12 months.
What is Novacyt’s market cap?
Novacyt’s market cap is €31.94M.
When is Novacyt’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Novacyt’s earnings last quarter?
Novacyt released its earnings results on Sep 30, 2026. The company reported -€0.093 earnings per share for the quarter.
Is Novacyt overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Novacyt pay dividends?
Novacyt does not currently pay dividends.
What is Novacyt’s EPS estimate?
Novacyt’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novacyt have?
Novacyt has 72,588,090 shares outstanding.
What happened to Novacyt’s price movement after its last earnings report?
Novacyt reported an EPS of -€0.093 in its last earnings report. Following the earnings report the stock price went down -1.563%.
Which hedge fund is a major shareholder of Novacyt?
Currently, no hedge funds are holding shares in DE:NYZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology